Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Škrha

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Vnitrni Lekarstvi|December 31, 2020
Hypoglycemia in non -diabetic patientsJan Škrha
Vnitrni Lekarstvi|October 8, 2022
Any expectations from the more powerful dulaglutide?Jan Škrha
Vnitrni Lekarstvi|December 7, 2016
[Short-term and long-term glycemic variability and its relationship to microvascular complications of diabetes]Martin Prázný, Jan Škrha, Jan Šoupal, et al.
Vnitrni Lekarstvi|October 8, 2022
ADA Standards of Medical Care in Diabetes 2022 - whats new?Jan Škrha
Vnitrni Lekarstvi|December 7, 2016
[Should we consider a new classification of diabetes influenced by therapeutic decisions?]Jan Škrha
Vnitrni Lekarstvi|April 21, 2015
[Glycation of lens proteins in diabetes and its non-invasive assessment - first experience in the Czech Republic]Jan Škrha, Jan Šoupal, Martin Prázný, et al.
Casopis Lekaru Ceskych|December 8, 2017
[Glycemic variability and microvascular complications of diabetes]Martin Prázný, Jan Škrha, Jan Šoupal, et al.
Vnitrni Lekarstvi|April 21, 2015
[Biosimilar insulines - new possibilities of diabetes treatment]Jan Škrha
Current Atherosclerosis Reports|January 19, 2021
Diabetes, Lipids, and CV RiskJan Škrha
Reviews in Endocrine & Metabolic Disorders|March 16, 2016
Glucose variability, HbA1c and microvascular complicationsJan Škrha, Jan Šoupal, Jan Škrha, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Vnitrni Lekarstvi|December 31, 2020
Hypoglycemia in non -diabetic patientsJan Škrha
Vnitrni Lekarstvi|October 8, 2022
Any expectations from the more powerful dulaglutide?Jan Škrha
Vnitrni Lekarstvi|December 7, 2016
[Short-term and long-term glycemic variability and its relationship to microvascular complications of diabetes]Martin Prázný, Jan Škrha, Jan Šoupal, et al.
Vnitrni Lekarstvi|October 8, 2022
ADA Standards of Medical Care in Diabetes 2022 - whats new?Jan Škrha
Vnitrni Lekarstvi|December 7, 2016
[Should we consider a new classification of diabetes influenced by therapeutic decisions?]Jan Škrha
Vnitrni Lekarstvi|April 21, 2015
[Glycation of lens proteins in diabetes and its non-invasive assessment - first experience in the Czech Republic]Jan Škrha, Jan Šoupal, Martin Prázný, et al.
Casopis Lekaru Ceskych|December 8, 2017
[Glycemic variability and microvascular complications of diabetes]Martin Prázný, Jan Škrha, Jan Šoupal, et al.
Vnitrni Lekarstvi|April 21, 2015
[Biosimilar insulines - new possibilities of diabetes treatment]Jan Škrha
Current Atherosclerosis Reports|January 19, 2021
Diabetes, Lipids, and CV RiskJan Škrha
Reviews in Endocrine & Metabolic Disorders|March 16, 2016
Glucose variability, HbA1c and microvascular complicationsJan Škrha, Jan Šoupal, Jan Škrha, et al.
Pageof 5